share_log

Novavax | 4: Statement of changes in beneficial ownership of securities-Director DOUGLAS RICHARD

Novavax | 4: Statement of changes in beneficial ownership of securities-Director DOUGLAS RICHARD

諾瓦瓦克斯醫藥 | 4:持股變動聲明-董事 DOUGLAS RICHARD
美股SEC公告 ·  06/14 16:16

Moomoo AI 已提取核心訊息

On June 12, 2024, Richard Douglas, associated with Novavax Inc [NVAX], completed a transaction to acquire 6,670 shares of the company's common stock at no cost. This transaction was categorized as an exercise or conversion of derivative security, which is typically related to options or warrants being converted into stock. Following this acquisition, Douglas directly holds a total of 43,920 shares in Novavax. The transaction reflects a continued investment in the company by an individual closely associated with it.
On June 12, 2024, Richard Douglas, associated with Novavax Inc [NVAX], completed a transaction to acquire 6,670 shares of the company's common stock at no cost. This transaction was categorized as an exercise or conversion of derivative security, which is typically related to options or warrants being converted into stock. Following this acquisition, Douglas directly holds a total of 43,920 shares in Novavax. The transaction reflects a continued investment in the company by an individual closely associated with it.
2024年6月12日,諾瓦瓦克斯醫藥(Novavax Inc [NVAX])的關聯人Richard Douglas完成了一筆交易,以零成本獲得了公司普通股6,670股。此交易被歸類爲衍生證券的行權或轉化,通常涉及期權或認股權轉換爲股票。完成此次收購後,道格拉斯在諾瓦瓦克斯醫藥直接持有43,920股。這筆交易反映了與該公司密切相關的個人對該公司的持續投資。
2024年6月12日,諾瓦瓦克斯醫藥(Novavax Inc [NVAX])的關聯人Richard Douglas完成了一筆交易,以零成本獲得了公司普通股6,670股。此交易被歸類爲衍生證券的行權或轉化,通常涉及期權或認股權轉換爲股票。完成此次收購後,道格拉斯在諾瓦瓦克斯醫藥直接持有43,920股。這筆交易反映了與該公司密切相關的個人對該公司的持續投資。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息